SCHEMBL7487928

SCHEMBL7487928

O=c1[nH]cc(C2c3ccccc3C=Cc3ccccc32)c(=O)[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ ATAD2 Q6PL18 1/20 0.40
▸ DPYD Q12882 2/20 0.38
▸ P2RY2 P41231 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ CYP1A2 P05177 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CYP19A1 P11511 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ THPO P40225 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HBB P68871 1/20 0.36
▸ PMP22 Q01453 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7598686 0.83 ALDH1A1 (0.49) ALDH1A1ATAD2DPYDMAPTGAA
SCHEMBL7511528 0.79 ATAD2 (0.33) ALDH1A1ATAD2P2RY2
SCHEMBL7488455 0.78 ATAD2 (0.40) ALDH1A1ATAD2DPYDP2RY2GAA
SCHEMBL7831877 0.78 KMT2A (0.39) ALDH1A1ATAD2DPYDP2RY2MAPT
SCHEMBL7841237 0.75 LMNA (0.42) ALDH1A1LMNA
SCHEMBL7840803 0.73 ATAD2 (0.38) ALDH1A1ATAD2P2RY2LMNATSHR
SCHEMBL7503494 0.73 LMNA (0.33) ALDH1A1ATAD2P2RY2MAPTGAA
SCHEMBL7486706 0.72 P2RY2 (0.37) ALDH1A1ATAD2P2RY2GAALMNA
SCHEMBL7490690 0.70 P2RY2 (0.40) ALDH1A1P2RY2LMNATSHRMEN1
SCHEMBL7841473 0.70 LMNA (0.37) ALDH1A1ATAD2P2RY2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000038-B1 NOVEL PYRIMIDIN DERIVATIVES ASTRAZENECA AB (SE) 2002-11-06 — — EP disclosed
EP-0996617-B1 2,4-Dithi(oxo)-pyridin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists ASTRAZENECA AB (SE) 2002-01-09 — — EP disclosed
EP-0984963-B1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2001-04-11 — — EP disclosed
US-6200981-B1 FOR TREATING INFLAMMATORY DISEASES SUCH AS ASTHMA, INFLAMMATORY BOWEL DISEASE, PSORIASIS, RHEUMATOID ARTHRITIS, MYOCARDIAL ISCHAEMIA, CYSTIC FIBROSIS, ARTHEREOSCLEROSIS, RESTENOSIS, PERIDONTAL DISEASE, SEPTIC SHOCK, OSTEOARTHRITIS ASTRAZENECA UK LIMITED (GB) 2001-03-13 — — US disclosed
US-6162808-A Compounds ASTRAZENECA U.K. LIMITED (GB) 2000-12-19 — — US disclosed
US-6107297-A 2,4-Dithi(oxo)-pyrimidin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists ASTRA PHARMACEUTICALS LIMITED (GB) 2000-08-22 — — US disclosed
Send feedback